Compare WAFD & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WAFD | PBH |
|---|---|---|
| Founded | 1917 | 1996 |
| Country | United States | United States |
| Employees | N/A | 890 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.4B |
| IPO Year | 1996 | 2004 |
| Metric | WAFD | PBH |
|---|---|---|
| Price | $28.44 | $49.23 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 7 |
| Target Price | $34.50 | ★ $67.80 |
| AVG Volume (30 Days) | ★ 1.1M | 493.5K |
| Earning Date | 10-15-2026 | 11-05-2026 |
| Dividend Yield | ★ 3.80% | N/A |
| EPS Growth | ★ 5.20 | N/A |
| EPS | ★ 2.45 | 0.61 |
| Revenue | $29,650,000.00 | ★ $975,777,000.00 |
| Revenue This Year | $127.22 | $17.03 |
| Revenue Next Year | $21.56 | $6.06 |
| P/E Ratio | ★ $11.62 | $81.80 |
| Revenue Growth | 7.79 | ★ 36.77 |
| 52 Week Low | $28.43 | $42.62 |
| 52 Week High | $39.49 | $71.07 |
| Indicator | WAFD | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 26.93 | 60.27 |
| Support Level | N/A | $49.73 |
| Resistance Level | $33.59 | $51.57 |
| Average True Range (ATR) | 0.61 | 1.24 |
| MACD | 0.07 | 0.52 |
| Stochastic Oscillator | 1.61 | 84.76 |
WaFd Inc is engaged in providing lending, depository, insurance, and other banking services to consumers, mid-sized to large businesses, and owners and developers of commercial real estate. Through the WaFd Bank, it is involved in accepting deposits from the general public and investing these funds in loans of various types, including first-lien mortgages on single-family dwellings, construction loans, land acquisition and development loans among others. The Bank also invests in certain United States government and agency obligations along with other investments and also performs insurance brokerage activities. Geographically, it operates in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, California and Texas.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.